ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Urology · World J Urol · 2026-11-17

In 57 men analysed after laparoscopic radical prostatectomy, opioid-free anaesthesia (dexmedetomidine plus ketamine) did not reduce 24-hour oxycodone use vs remifentanil-based anaesthesia (−2.0 mg; p=0.556); pain and PONV were similar. Recruitment was curtailed.

Secondary analysisn = 57
Maciejewski et al. Opioid-free anaesthesia versus opioid-based anaesthesia for laparoscopic radical prostatectomy: a prespecified analysis of a single-centre randomized controlled trial
Urology · World J Urol · 2026-10-28

In habitual wine drinkers having elective urological surgery, 30 days of controlled postoperative red wine versus abstinence did not improve SF-36 Mental Health Index change (difference 1.3 points; p=0.4); complications and readmissions did not differ significantly.

RCT
Capitanio et al. Controlled postoperative red wine intake versus abstinence in habitual wine drinkers undergoing elective urological surgery (WISE): a translational randomized controlled trial assessing quality of life, surgical outcomes and complications
Urology · World J Urol · 2026-09-28

In a systematic review of 18 trials (16 network meta-analysed) of add-on therapy for persistent overactive bladder symptoms in α1-blocker-treated men with BPH, vibegron cut micturitions (−0.81/24 h) and urgency versus control; no clear advantage over mirabegron was shown.

Meta-analysisn = 18 trials
Yajima et al. Vibegron, mirabegron, and other add-on therapies for persistent overactive bladder symptoms in α1-blocker-treated men with benign prostatic hyperplasia: a systematic review and Bayesian network meta-analysis
Urology · World J Urol · 2026-09-15

Meta-analysis of 7 comparative populations (3,509 men; mostly low/very low certainty) found thulium fibre laser and conventional holmium laser prostate enucleation clinically comparable; IPSS at 3 months was slightly lower with thulium (MD −1.04), of uncertain relevance.

Meta-analysisn = 3,509
Valdez-Gil et al. Efficacy and safety of thulium fiber laser versus conventional holmium:YAG laser in anatomical endoscopic enucleation of the prostate: a systematic review and pairwise meta-analysis
Urology · Eur Urol Oncol · 2026-08-13

Secondary analysis of the phase 3 PROpel trial in first-line metastatic castration-resistant prostate cancer: olaparib plus abiraterone vs placebo plus abiraterone numerically favoured rPFS in BRCA2 (HR 0.20), ATM (HR 0.55) and CDK12 (HR 0.51) mutation subgroups.

Secondary analysis
Shore et al. Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel
Urology · World J Urol · 2026-08-04

Meta-analysis of 43 studies (3847 patients; 2730 pooled) of the UroLume stent for bulbar urethral stricture or BPH: pooled restenosis/tissue ingrowth 37.9%, stent explantation 8.7%, urinary incontinence 9.7%. A model estimates fewer than 100 severely affected patients globally.

Meta-analysisn = 3,847
Kapos The UroLume endoprosthesis and UroLume cripple syndrome: a systematic review and meta-analysis of pathophysiology, complications, surgical management, psychological burden, and epidemiology of surviving patients worldwide
Urology · Prostate Cancer Prostatic Dis · 2026-08-03

Meta-analysis of 8 retrospective studies after radical prostatectomy: cribriform pattern or intraductal carcinoma (prevalence 27%) was associated with biochemical recurrence (univariable HR 2.76; adjusted for stage and Grade Group HR 2.59, 95% CI 1.44-4.67).

Meta-analysisn = 8 trials
Ditonno et al. Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations
Urology · World J Urol · 2026-07-26

Meta-analysis of 7 comparative studies (>500 men, 1 RCT): concomitant prostate enlargement and bladder stone surgery vs stone surgery alone was associated with less stone recurrence (OR 0.18) and better IPSS, but more minor complications (OR 4.35).

Meta-analysisn = 7 studies
Cormio et al. Concomitant benign prostatic enlargement and bladder stone surgery versus bladder stone treatment alone: results from a systematic review and meta-analysis of comparative studies by the EAU endourology section
Urology · J Urol · 2026-07-16

AUA/SUO guideline amendment (Part I) updates recommendations on imaging, germline and somatic testing, and treatment of biochemically recurrent prostate cancer after exhaustion of local therapy and of metastatic hormone-sensitive prostate cancer, drawing on 38 studies reviewed.

Guidelinen = 38 studies
Scarpato et al. Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer
Urology · Eur Urol · 2026-07-11

In 648 mostly biopsy-naive men with PI-RADS ≥3 lesions in China, cognitive fusion targeted biopsy was non-inferior to software fusion for detecting clinically significant prostate cancer (32% vs 34%; risk difference -1.02 points), though software did better at BMI ≥24.

RCTn = 648
He et al. Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION)

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.